Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2a, Double-blind, Placebo-controlled Study of the Safety and Pharmacokinetics of XOMA 052 in Subjects With Type 2 Diabetes Mellitus

NCT00513214 is registered in ClinicalTrials.gov with XOMA (US) LLC as lead sponsor.

NCT NCT00513214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00513214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2a, Double-blind, Placebo-controlled Study of the Safety and Pharmacokinetics of XOMA 052 in Subjects With Type 2 Diabetes Mellitus
Lead sponsor
XOMA (US) LLC
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2007
Completion date
February 28, 2010
Enrollment
68 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes